Mainit, Rosety-an O.
HRN: 18-85-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CEFUROXIME 1.5GM (VIAL)
05/30/2022
05/31/2022
IVT
1.5gm
IVT Now Then Q8 X 2 More Doses
Primary LTCS With PPIUD
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes